Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Zepbound Tops Wegovy for Weight Loss
Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
Eli Lilly’s Weight-Loss Drug Zepbound More Effective than Novo’s Wegovy, Study Shows
New data indicating Eli Lilly’s obesity shot Zepbound works better than Novo Nordisk’s Wegovy could add fuel to Lilly’s new efforts to market the drug as shortages ease.Recent months have brought new questions about whether the sky-high expectations for Zepbound’s sales—which have sent Lilly’s share price up more than 230% over the past three years—may be overly optimistic.
Eli Lilly's Zepbound beats Wegovy in head-to-head weight loss trial
Eli Lilly said patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in a study.
FiercePharma
1d
Eli Lilly's Zepbound defeats Novo Nordisk's Wegovy in head-to-head weight loss trial
Over the last two-plus years, as Eli Lilly and Novo Nordisk have battled for their share of the massive weight loss market ...
2d
Eli Lilly’s Growth Driven by Strong Prescription Trends for Mounjaro and Zepbound
Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) and increased the price target ...
5d
Why Is Lilly (LLY) Down 5% Since Last Earnings Report?
Lilly (LLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
French government falls
Fox News commentator dies
Recuses himself from case
Congress halts Ukraine aid
US telecom firms hacked
Independent run for gov.
Leaded gas health risk
MX record fentanyl bust
UnitedHealthcare CEO killed
Denied place on ballot
Theriault ends recount
Warns iPhone, Android users
Rockefeller tree lights up
Tops $100K for the first time
DOJ: MPD bias against Blacks
Rock band robbed in CA
Composer Laird dies at 85
Atkins tapped as SEC chair
Sun hire new head coach
Students' math skills decline
Private payrolls grew 146K
Asteroid nearly hits Earth
California school shooting
Says he won’t back down
3-week reprieve from prison
Deportation flights ruling
DC AG sues Amazon
Tapped for key trade role
Picked to head NASA
Celtics out of NBA Cup
US Space Force unit in Japan
Asks for new trial
Ex-priest pleads guilty
Related topics
Wegovy
Novo Nordisk
Amgen
Feedback